OEM Manufacturer Colistin Sulphate Powder For Soluble - Neomycin Sulfate Soluble Powder – Jizhong
OEM Manufacturer Colistin Sulphate Powder For Soluble - Neomycin Sulfate Soluble Powder – Jizhong Detail:
Composition:
Per g 10% neomycin sulfate powder contains: neomycin sulfate 100mg
Indication:
10% neomycin sulfate powderhas excellent activity against gram negative bacteria such as e. coli, salmonella, and pasteurella multocida. staphylococcus aureus is also sensitive to this compound.
oral administration can cure intestinal infection. pharmacokinetics after oral administration, 3% of neomycin is eliminated mainly via urine.
enteral infections caused by gram-negative bacteria
Adverse Reaction:
10% neomycin sulfate powder ,long-term use will induce kidney and ear damage.
Caution:
10% neomycin sulfate powder is prohibited to use during laying period.
Withholding Period:
10% neomycin sulfate powder for chicken: 5 days
Storage:
10% neomycin sulfate powder should be closed tight, store in dry place.
Shelf Life:
When stored properly, neomycin sulfatepowder has a useful life of 24 months from the day of production.
Keep out of the touch of children, and dry place, avoid sunlight and light
Product detail pictures:
Related Product Guide:
Reliable quality and good credit standing are our principles, which will help us at a top-ranking position. Adhering to the tenet of "quality first, customer supreme" for OEM Manufacturer Colistin Sulphate Powder For Soluble - Neomycin Sulfate Soluble Powder – Jizhong , The product will supply to all over the world, such as: Manchester, Ghana, United States, We have advanced production technology, and pursuit innovative in products. At the same time, the good service has enhanced the good reputation. We believe that as long as you understand our product, you must be willing to become partners with us. Looking forward to your inquiry.
By Barbara from Pakistan - 2017.11.29 11:09
Good quality, reasonable prices, rich variety and perfect after-sales service, it's nice!
By Alexandra from Canberra - 2017.09.30 16:36